Extranodal NK-T-cell lymphoma epidemiology and demographics
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics |
FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics |
CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics |
Extranodal NK-T-cell lymphoma epidemiology and demographics in the news |
Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
Epidemiology and Demographics
Mortality rate
- NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.
Race
- Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
- Nk cell lymphoma is usually associated with Epstein-Barr virus infection.
Gender
- There is no established difference between male and female prevalence of extranodal NK cell lymphoma.
Region
- NK T cell lymphoma, nasal type (NNKTL) consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.
- It is estimated the incidence of NNKTL is higher in Asia by 10-folds.
Age